Peracetic acid is the high-level disinfectant most closely associated with dialysis, endoscopy, and laboratory settings. It works by oxidizing microbial proteins and nucleic acids, and it breaks down into acetic acid, water, and oxygen. It is supplied as a balanced equilibrium mixture of peracetic acid, hydrogen peroxide, acetic acid, and water. In dialysis, it is used to clean and disinfect dialyzers and distribution loops; in endoscopy, it reprocesses heat-sensitive instruments such as bronchoscopes and duodenoscopes; in laboratories, it decontaminates surfaces, glassware, and equipment. The rest of this explainer covers why its chemistry suits those settings, where it fails, and how practice differs from marketing.
Mechanism: how peracetic acid kills
Peracetic acid (PAA, CH3COOOH) is a peroxy acid. Its oxygen-oxygen bond is weak, and the molecule donates reactive oxygen species that attack microbial cell walls, proteins, and nucleic acids. Because the attack is oxidative rather than a single-site block, resistance is unlikely to emerge the way it does with some antibiotics. That is why PAA sits at the high-level disinfectant tier alongside glutaraldehyde and ortho-phthalaldehyde.
The chemistry matters for reprocessing. When PAA contacts organic soil, the oxidant is consumed first by blood, mucus, or biofilm, so disinfection fails if cleaning is skipped. In dialysis, residual blood protein in a dialyzer header can protect biofilm from the disinfectant. In endoscopy, a contaminated channel lumen or a damaged elevator mechanism can harbor organisms that the disinfectant never reaches.
Formulation matters too. A stabilized PAA solution maintains a measurable PAA concentration during reuse, but the concentration drops as it oxidizes soil. Users monitor concentration with test strips or titration. If the strip result falls below the label minimum, the solution is discarded. The point: PAA is not a set-and-forget chemistry. Its efficacy tracks its measured concentration, not its label.
Quantified context: concentrations, contact times, and settings
PAA products are formulated at different strengths. Typical high-level disinfectant formulations contain roughly 0.1 to 0.5 percent PAA, sometimes paired with 1 to 5 percent hydrogen peroxide. Contact times depend on the product label and the claimed organism spectrum. Manufacturer labels commonly specify several minutes for high-level disinfection and longer for sporicidal claims. These are label claims, not universal rules, and the label governs any health care use.
In dialysis, the relevant chemistry is often a peracetic acid-based cleaning and disinfection product for dialyzer reuse or distribution systems. Regulatory and professional guidance requires that reuse programs follow the manufacturer's instructions and validate performance locally. That validation is the concrete number that matters: it is a measured log reduction or a residual chemical test, not a slogan.
In endoscopy, high-level disinfection is the default for heat-sensitive scopes. Published guidance from gastroenterology and infection-control societies emphasizes manual cleaning before any chemical disinfection, then concentration monitoring and documented contact time. The practical numbers are the label contact time and the daily or per-batch verification of the disinfectant's concentration.
In laboratories, PAA is used for surface decontamination and for disinfecting items that cannot tolerate heat. Concentrations and contact times vary by product and by the target organism. Without a labeled claim, no number is meaningful.
Edge cases where PAA underperforms
The most important edge case is biofilm. PAA penetrates biofilm poorly relative to a clean surface, and the oxidant is consumed by the matrix before it reaches the cells. A scope channel with a biofilm layer can survive a label contact time. This is why cleaning and visual inspection come first.
Material compatibility is another edge case. PAA is corrosive to some metals, particularly soft metals and certain alloys, and prolonged exposure can degrade elastomers, seals, and optical components. Scopes and dialysis equipment must be validated for compatibility with the specific product.
Residual toxicity matters. PAA and its byproducts can irritate skin, eyes, and airways. Dialysis patients are exposed to residual disinfectant if not properly rinsed, so rinse steps and residual testing are essential.
Concentration decay is a practical edge case. PAA loses activity over time and with use, more quickly when warm or contaminated. A solution that measured correctly in the morning may fail in the afternoon.
Red flag: a reprocessing step that skips manual cleaning before disinfection. Red flag: a PAA solution used past its measured concentration or beyond its reuse interval. Red flag: a scope or dialyzer component not validated for PAA compatibility. Red flag: residual disinfectant not removed before patient contact. Red flag: a documented sterilization claim used to justify high-level disinfection.
Misconceptions and a professional caveat
Peracetic acid is not the same as hydrogen peroxide. Hydrogen peroxide is a related oxidant, but PAA is a distinct chemical with its own label claims, contact times, and compatibility profiles. Treating them as interchangeable can invalidate a reprocessing protocol.
PAA is not a sterilant in every context. Some formulated products carry sporicidal claims, but a sporicidal claim depends on concentration, contact time, temperature, and soil load. A high-level disinfectant claim is a lower bar than a sterilization claim.
The counterintuitive caveat is that PAA does not fix a dirty instrument. Its main failure mode in endoscopy is inadequate cleaning, not inadequate chemical potency. A more concentrated solution applied to a biofilm-laden channel can perform worse than a properly cleaned channel with a lower concentration.
Alternatives compared
| Disinfectant | Typical chemistry | Common setting | Key strength | Key limitation |
|---|---|---|---|---|
| Peracetic acid | Peroxy acid with H2O2 and acetic acid | Dialysis, endoscopy, labs | Fast oxidative action, breaks down to benign residues | Corrosive to some materials; concentration decays |
| Glutaraldehyde | Aldehyde | Endoscopy, some labs | Long track record, broad label claims | Irritant and sensitizer; slower action |
| Ortho-phthalaldehyde | Aldehyde | Endoscopy | Less irritating than glutaraldehyde | Staining risk; material compatibility issues |
| Hydrogen peroxide | Peroxide | Surface and instrument disinfection | Broad availability | Narrower high-level claims; material compatibility |
| Chlorine-based | Hypochlorite | Surface and lab decontamination | Fast, cheap, broad spectrum | Corrosive; inactivated by organic soil |
This table is qualitative on purpose. Which product a facility uses depends on validated compatibility, label claims, and local regulation, not on a single ranking.
Timeline of a reprocessing cycle
| Step | What happens | Why it matters |
|---|---|---|
| Pre-clean | Visible soil removed at point of use | Prevents soil from drying and protecting microbes |
| Manual clean | Channels brushed, enzyme detergent, rinse | Removes biofilm and protein that consume PAA |
| Concentration check | Test strip or titration | Confirms PAA is at or above label minimum |
| Disinfection soak | Label contact time at stated temperature | Delivers the claimed log reduction |
| Rinse | Residual PAA removed per label | Prevents chemical injury to patient or equipment |
| Dry and store | Channels dried and hung vertically | Moisture enables biofilm regrowth |
| Documentation | Batch, concentration, contact time recorded | Enables traceability and audit |
Practical actions
Users can make PAA reprocessing reliable by following a few steps. Read the product label for the specific claim and contact time. Validate compatibility with the actual scope or dialysis equipment. Measure PAA concentration before each use and document the result. Maintain a cleaning step that is audited, not assumed. Remove residual disinfectant per the label before patient contact. Investigate any failure in concentration or cleaning before continuing to use the solution.
For dialysis programs, the reuse protocol must follow manufacturer instructions and local validation. For endoscopy units, the high-level disinfection process should include concentration monitoring and channel inspection. For laboratory use, the product label defines the target organisms and contact time.
Limitations
The evidence base for PAA is strong on mechanism and label efficacy, but real-world performance depends on cleaning, concentration, contact time, temperature, and material compatibility. Published guidance stresses process controls rather than a single product choice. The concentrations and contact times described here are illustrative of labeled products and must not be applied as universal values. Any conclusion about a specific product requires its label and its validation data.
This article is general educational information, not a diagnosis, treatment plan, or infection-control prescription. Reprocessing decisions for medical devices and dialysis equipment require the manufacturer's instructions and a qualified local professional. If you suspect a reprocessing failure or an exposure, follow local infection-control and emergency procedures.